Answers are grounded in this paper and cite their sources.
OBJECTIVE: To provide pooled estimates of response to conservative treatment in women with myoinvasive endometrial carcinoma (EC). DATA SOURCES: A systematic review and meta-analysis was performed by searching 6 electronic databases from their inception to December 2025. METHODS OF STUDY SELECTION: Studies that provided extractable data on response outcomes of conservative treatment in women with myoinvasive EC. TABULATION, INTEGRATION, AND RESULTS: Pooled prevalence rates for complete response (CR), partial response (PR), stable disease (SD), progressive disease (PD) and recurrence to conservative treatment in women with myoinvasive EC were calculated for each included study and as pooled estimates, with 95% confidence interval (CI). Three retrospective, observational, cohort studies assessing 39 women with EC with myometrial invasion < 50%, who underwent fertility-sparing treatment, were included. Pooled prevalence was 82% (95% CI: 66%-94%) for CR, 3% (95% CI: 0%-14%) for PR, 13% (95% CI: 3%-27%) for SD, 0% (95% CI: 0%-4%) for PD and 37% (95% CI: 11%-66%) for recurrence. CONCLUSIONS: Fertility-sparing management of EC with myometrial invasion <50% showed a high rate of CR and a recurrence rate slightly higher than that reported in literature for EC without myometrial invasion. Although conservative treatment of EC with myometrial invasion <50% cannot be considered a standard of care to date, these findings may warrant prospective evaluation in carefully selected patients managed in specialized centers with intensive surveillance.
No takes yet. Share an insight, caveat, or question.
Raffone et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: